ADLM 2024 BOLD MOVE.

Lipoprotein(a): Laboratory Testing and Clinical Use

Tuesday, July 30th
6:00 - 7:30 p.m.
Location: Hyatt Regency McCormick Place
Room: Hyde Park
Sponsored by Helena Laboratories 

Overview

Lipoprotein(a) [Lp(a)] is a member of the ApoB family of lipoproteins which bears independent risk of atherosclerotic cardiovascular events.  Approximately 20% of individuals have elevated Lp(a); most of these patients are unaware of the risk because screening for Lp(a) is not routinely implemented in clinical practice.  Here we will discuss these aspects, standard and esoteric testing for Lp(a) and how the complexity of the molecular structure of this biomarker influences measurements and challenges the clinical laboratory. Further we will explain how those results can guide clinical management of patients at risk, and influence cascade family testing strategies.

Moderator

Robert S. Galen, MD MPH
Professor Emeritus Epidemiology and Biostatistics, University of Georgia - College of Public Health

Speaker(s)

Leslie J Donato, PhD
Co-Director, Hospital Clinical Laboratory, Division of Clinical Core Laboratory Services, The Mayo Clinic

Vlad C Vasile, MD PhD
Assistant Professor Laboratory Medicine and Pathology; Consultant-Division of Preventive Cardiology, The Mayo Clinic